Literature DB >> 21543489

Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses.

Wendy C L Yu1, Renee W Y Chan, Jieru Wang, Emily A Travanty, John M Nicholls, J S Malik Peiris, Robert J Mason, Michael C W Chan.   

Abstract

Highly pathogenic influenza H5N1 virus continues to pose a threat to public health. Although the mechanisms underlying the pathogenesis of the H5N1 virus have not been fully defined, it has been suggested that cytokine dysregulation plays an important role. As the human respiratory epithelium is the primary target cell for influenza viruses, elucidating the viral tropism and innate immune responses of influenza H5N1 virus in the alveolar epithelium may help us to understand the pathogenesis of the severe pneumonia associated with H5N1 disease. Here we used primary cultures of differentiated human alveolar type II cells, alveolar type I-like cells, and alveolar macrophages isolated from the same individual to investigate viral replication competence and host innate immune responses to influenza H5N1 (A/HK/483/97) and H1N1 (A/HK/54/98) virus infection. The viral replication kinetics and cytokine and chemokine responses were compared by quantitative PCR (qPCR) and enzyme-linked immunosorbent assay (ELISA). We demonstrated that influenza H1N1 and H5N1 viruses replicated productively in type II cells and type I-like cells although with different kinetics. The H5N1 virus replicated productively in alveolar macrophages, whereas the H1N1 virus led to an abortive infection. The H5N1 virus was a more potent inducer of proinflammatory cytokines and chemokines than the H1N1 virus in all cell types. However, higher levels of cytokine expression were observed for peripheral blood monocyte-derived macrophages than for alveolar macrophages in response to H5N1 virus infection. Our findings provide important insights into the viral tropisms and host responses of different cell types found in the lung and are relevant to an understanding of the pathogenesis of severe human influenza disease.

Entities:  

Mesh:

Year:  2011        PMID: 21543489      PMCID: PMC3126566          DOI: 10.1128/JVI.02200-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

Review 1.  Inflammation in wound repair: molecular and cellular mechanisms.

Authors:  Sabine A Eming; Thomas Krieg; Jeffrey M Davidson
Journal:  J Invest Dermatol       Date:  2007-03       Impact factor: 8.551

2.  Differentiated human alveolar epithelial cells and reversibility of their phenotype in vitro.

Authors:  Jieru Wang; Karen Edeen; Rizwan Manzer; Yongsheng Chang; Shuanglin Wang; Xueni Chen; C Joel Funk; Gregory P Cosgrove; Xiaohui Fang; Robert J Mason
Journal:  Am J Respir Cell Mol Biol       Date:  2007-01-25       Impact factor: 6.914

3.  Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice.

Authors:  Kristy J Szretter; Shivaprakash Gangappa; Xuihua Lu; Chalanda Smith; Wun-Ju Shieh; Sherif R Zaki; Suryaprakash Sambhara; Terrence M Tumpey; Jacqueline M Katz
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

Review 4.  [Influenza virus receptors in the human airway].

Authors:  Kyoko Shinya; Yoshihiro Kawaoka
Journal:  Uirusu       Date:  2006-06

5.  Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules.

Authors:  Susanne Herold; Werner von Wulffen; Mirko Steinmueller; Stephan Pleschka; William A Kuziel; Matthias Mack; Mrigank Srivastava; Werner Seeger; Ulrich A Maus; Juergen Lohmeyer
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

6.  Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs.

Authors:  Heui Man Kim; Young-Won Lee; Ki-Ja Lee; Hyun Soo Kim; Sung Whan Cho; Nico van Rooijen; Yi Guan; Sang Heui Seo
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

Review 7.  The pathology of influenza virus infections.

Authors:  Jeffery K Taubenberger; David M Morens
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

8.  Acute lung injury edema fluid decreases net fluid transport across human alveolar epithelial type II cells.

Authors:  Jae W Lee; Xiaohui Fang; Gregory Dolganov; Richard D Fremont; Julie A Bastarache; Lorraine B Ware; Michael A Matthay
Journal:  J Biol Chem       Date:  2007-06-19       Impact factor: 5.157

Review 9.  Avian influenza virus (H5N1): a threat to human health.

Authors:  J S Malik Peiris; Menno D de Jong; Yi Guan
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

10.  Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses.

Authors:  John M Nicholls; Anthony J Bourne; Honglin Chen; Yi Guan; J S Malik Peiris
Journal:  Respir Res       Date:  2007-10-25
View more
  82 in total

1.  Editorial: macrophage heterogeneity and responses to influenza virus infection.

Authors:  Suki M Y Lee; Isabelle Dutry; J S Malik Peiris
Journal:  J Leukoc Biol       Date:  2012-07       Impact factor: 4.962

2.  Virus-infected alveolar epithelial cells direct neutrophil chemotaxis and inhibit their apoptosis.

Authors:  Joanna P Rzepka; Anoria K Haick; Tanya A Miura
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02-03       Impact factor: 6.914

3.  Toll-like receptor 10 is involved in induction of innate immune responses to influenza virus infection.

Authors:  Suki M Y Lee; Kin-Hang Kok; Martial Jaume; Timothy K W Cheung; Tsz-Fung Yip; Jimmy C C Lai; Yi Guan; Robert G Webster; Dong-Yan Jin; J S Malik Peiris
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

Review 4.  How the Respiratory Epithelium Senses and Reacts to Influenza Virus.

Authors:  Kambez H Benam; Laura Denney; Ling-Pei Ho
Journal:  Am J Respir Cell Mol Biol       Date:  2019-03       Impact factor: 6.914

5.  AIM2 Inflammasome Is Critical for Influenza-Induced Lung Injury and Mortality.

Authors:  Hongbo Zhang; Jiadi Luo; John F Alcorn; Kong Chen; Songqing Fan; Joseph Pilewski; Aizhong Liu; Wei Chen; Jay K Kolls; Jieru Wang
Journal:  J Immunol       Date:  2017-04-19       Impact factor: 5.422

6.  In vivo imaging of the pathophysiological changes and neutrophil dynamics in influenza virus-infected mouse lungs.

Authors:  Hiroshi Ueki; I-Hsuan Wang; Satoshi Fukuyama; Hiroaki Katsura; Tiago Jose da Silva Lopes; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

7.  Alternative Progenitor Lineages Regenerate the Adult Lung Depleted of Alveolar Epithelial Type 2 Cells.

Authors:  Min Yee; William Domm; Robert Gelein; Karen L de Mesy Bentley; R Matthew Kottmann; Patricia J Sime; B Paige Lawrence; Michael A O'Reilly
Journal:  Am J Respir Cell Mol Biol       Date:  2017-04       Impact factor: 6.914

8.  The hemagglutinin protein of highly pathogenic H5N1 influenza viruses overcomes an early block in the replication cycle to promote productive replication in macrophages.

Authors:  Troy D Cline; Erik A Karlsson; Bradley J Seufzer; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

9.  Compromised respiratory function in lethal influenza infection is characterized by the depletion of type I alveolar epithelial cells beyond threshold levels.

Authors:  Catherine J Sanders; Peter Vogel; Jennifer L McClaren; Resha Bajracharya; Peter C Doherty; Paul G Thomas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-01-25       Impact factor: 5.464

Review 10.  Use of ex vivo and in vitro cultures of the human respiratory tract to study the tropism and host responses of highly pathogenic avian influenza A (H5N1) and other influenza viruses.

Authors:  Renee W Y Chan; Michael C W Chan; John M Nicholls; J S Malik Peiris
Journal:  Virus Res       Date:  2013-05-15       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.